New Guidance for Police on Interactions with Medical Cannabis Patients in the UK

As dusk descended on a small town in England, a 48-year-old woman named Lydia sat nervously in her car, a black canister containing her medical cannabis at her side. Recently prescribed CBD oil for her chronic pain, she had become all too familiar with anxiety off and on the road. Just weeks prior, she had been stopped by a police officer while on her way to a friend’s house. The officer had questioned her about the substance, forcing her to justify her legal use of the cannabis-based product. What stood as a solution to her pain morphed into an interrogation, fueled by outdated policing practices.

In response to such challenging encounters, police forces across the UK have received new guidance aimed at reshaping their interactions with medical cannabis patients. The National Police Chiefs Council (NPCC) recently approved instructions prepared by the Association of Police Controlled Drug Liaison Officers (APCDLO). This marks a pivotal shift, asking officers to “treat medicinal cannabis users as patients first, suspects second.”

A Long-Awaited Change

This new directive comes more than seven years after cannabis-based products for medicinal use (CBPMs) transitioned from Schedule 1 to Schedule 2 of the Misuse of Drugs Regulations in November 2018, thereby making them legal to possess with a valid prescription. Richard List, a retired Detective Chief Superintendent and lead author of the guidance, expressed deep concerns about the police service’s earlier stance toward medical cannabis. “The draft guidance circulating in 2024 was both outdated and incorrect,” List remarked. “Engaging with healthcare experts and other stakeholders is critical as this area evolves.”

Practical Engagements for Frontline Officers

The guidance delineates several practical strategies for officers when encountering patients who use medical cannabis:

• Request original packaging, including the dispensing label.
• Ask to see a letter from the prescriber or a copy of the prescription, though patients are not legally required to carry these documents.
• Assume individuals in possession of medicinal cannabis are patients until proven otherwise, only pursuing further actions if there are justifiable grounds for doubt.

As the guidance outlines, “it should be assumed that people in possession of medicinal cannabis are patients until proven otherwise.” Such a paradigm shift could mitigate unnecessary confrontations and ease the psychological burden faced by patients like Lydia, who should not have to fear the law when seeking relief from chronic conditions.

Addressing Controversial Areas

The recently released document probes into contentious initiatives, such as Cancard—plastic cards that signify the holder has a condition treatable with cannabis but do not serve as proof of a prescription. The guidance clarifies a crucial point: patients with legal prescriptions do not require a Cancard, which imposes an annual fee for its use. “It seems absurd to charge patients for something that they should not need if they can prove their legal status with a prescription,” remarked Dr. Helen Matthews, a researcher in medical cannabis laws.

Medical Cannabis and Its Users

According to the guidance authored by List, medical cannabis patients are often grappling with severe ailments, rendering them likely to suffer from chronic pain or other debilitating conditions. CBPMs are prescribed only when conventional treatments have failed. For many patients, these products offer a lifeline, a way to navigate through their daily lives without the overshadowing pain that constant medication has not alleviated.

However, the potential for police interactions still looms large, particularly as public awareness and understanding continue to lag behind legislation. “What we need is education, both for officers and the general public,” asserted List. “Many still perceive cannabis predominantly as a recreational drug, failing to realize its medicinal applications.”

A Future of Ongoing Conversations

Though the NPCC has initiated reforms, List acknowledges that the guidance will likely require further revisions as the landscape of medical cannabis continues to evolve. “It’s essential that we remain open to feedback and further collaboration with private producers, healthcare partners, and the wider cannabis community,” he stated.

The ongoing dissemination of the document has been welcomed across police forces in England, Scotland, and Wales. But many stakeholders emphasize that immediate training and public awareness campaigns will be needed to ensure the changes are understood and implemented effectively. “It’s not just about issuing new guidelines; it’s about cultural transformation within policing,” suggested Dr. Ian Carter, a lobbyist advocating for cannabis reform.

As Lydia took a deep breath and opened her canister in the quiet of her car, she could only hope that future encounters with law enforcement would reflect the new approach. Her story is one of many—an example of both the challenges and opportunities arising in the brave new world of medical cannabis legislation in the UK.

Source: www.leafie.co.uk